T. Argentieri

发表

Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice.

T. Colatsky, P. Babij, G. R. Askew, 1998, Circulation research.

An overview of potassium channel activators for the treatment of overactive bladder: a survey of new structures 2000 – 2005

T. Argentieri, J. Butera, 2006 .

Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat.

T. Colatsky, S. Antane, T. Argentieri, 1999, The Journal of pharmacology and experimental therapeutics.

Inhibition of guinea pig detrusor contraction by NS-1619 is associated with activation of BKCa and inhibition of calcium currents.

T. Argentieri, N. Norton, J. Sheldon, 1997, The Journal of pharmacology and experimental therapeutics.

Synthesis and Potassium Channel Opening Activity of Substituted 10H-Benzo[4,5]furo[3,2-b]indole- and 5,10-Dihydro-indeno[1,2-b]indole-1-carboxylic Acids.

S. Antane, T. Argentieri, J. Butera, 2001 .

Efficacy of the beta3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat.

T. Argentieri, N. Norton, M. Woods, 2001, The Journal of urology.

Cellular Electrophysiological Effects of the Class III Antiarrhythmic Agents Sematilide and Clofilium on Rabbit Atrial Tissues

M. Carroll, T. Argentieri, M. Sullivan, 1991, Journal of cardiovascular pharmacology.

Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents.

R. DeVita, D. Davey, R. Gomez, 1987, Journal of medicinal chemistry.

Electrophysiological specificity of antiarrhythmic drugs: Is it necessary?

T. Argentieri, M. Sullivan, K. Sansone, 1990 .

Potassium channel blockers as antiarrhythmic drugs

Thomas M. Argentieri, Thomas J. Colatsky, T. Colatsky, 1994 .

Synthesis and potassium channel opening activity of substituted 10H-benzo[4,5]furo[3,2-b]indole-and 5,10-dihydro-indeno[1,2-b]indole-1-carboxylic acids.

S. Antane, T. Argentieri, J. Butera, 2001, Bioorganic & medicinal chemistry letters.

Synthesis and bladder smooth muscle relaxing properties of substituted 3-amino-4-aryl-(and aralkyl-)cyclobut-3-ene-1,2-diones.

T. Argentieri, J. Butera, N. Norton, 2005, Bioorganic & medicinal chemistry letters.

Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.

K. Rhodes, Y. Lee, T. Argentieri, 2003, Brain research. Molecular brain research.

Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.

M. Carroll, T. Argentieri, M. Sullivan, 1993, Journal of cardiovascular pharmacology.

Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents.

G. Phillips, R. Gomez, W. C. Lumma, 1992, Journal of medicinal chemistry.

Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 2. Selective and potent benzylamino cyclobutenediones.

A. Gilbert, G. Francisco, T. Argentieri, 2000, Journal of medicinal chemistry.

Recent approaches to the treatment of urinary incontinence: a survey of patent activity from 1995 to 1998

T. Argentieri, J. Butera, 1998 .

Optical micturition interval monitor for experimental animals.

T. Argentieri, M. Argentieri, 2002, Journal of pharmacological and toxicological methods.

Sensitivity of skeletal muscle to 20,25-diazacholesterol-induced myotonia requires normal innervation

J. McArdle, T. Argentieri, A. D'Alonzo, 1982, Experimental Neurology.

The etiology of toxic peripheral neuropathies: In vitro effects of acrylamide and 2,5-hexanedione on brain enolase and other glycolytic enzymes

T. Argentieri, H. Lowndes, R. D. Howland, 1980, Brain Research.

Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents.

R. Gomez, T. Argentieri, M. Sullivan, 1990, Journal of medicinal chemistry.

Metabolism and electrophysiology in subendocardial Purkinje fibers after infarction.

K. Lurie, F. Matschinsky, T. Argentieri, 1987, American Journal of Physiology.

Acute administration of 17 beta-estradiol inhibits calcium currents in isolated guinea pig detrusor myocytes.

T. Argentieri, J. Sheldon, 1995, The Journal of pharmacology and experimental therapeutics.

Antiarrhythmic peptide has no direct cardiac actions

E. Cantor, T. Argentieri, J. Wiggins, 1989, Experientia.

Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds. 2.

D. Davey, C. Wan, W. C. Lumma, 1987, Journal of medicinal chemistry.

Electrical properties of canine subendocardial Purkinje fibers surviving in 1-day-old experimental myocardial infarction.

T. Colatsky, T. Argentieri, L. H. Frame, 1990, Circulation research.

Monthly Update Cardiovascular & Renal: Sword: Impact on antiarrhythmic drug discovery?

T. Argentieri, J. Primeau, 1995 .

Characteristics of synaptic transmission in reinnervating rat skeletal muscle

S. Laxminarayan, J. McArdle, T. Argentieri, 1992, Pflügers Archiv.

Interaction of the opiate antagonist, naltrexone methyl bromide, with the acetylcholine receptor system of the motor end-plate

J. McArdle, T. Argentieri, 1983, Brain Research.

Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.

S. Antane, T. Argentieri, W. Spinelli, 2000, Journal of medicinal chemistry.

“Disinactivation” of N-type Inactivation of Voltage-gated K Channels by an Erbstatin Analogue*

K. Rhodes, W. Childers, T. Argentieri, 2004, Journal of Biological Chemistry.